Datar Cancer Genetics Announces Foray Into The United States With A $250M Contract To Offer Pioneering Cancer Detection Liquid Biopsies
Hover to Know More
Published on: 09 May, 2022
Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services Hover to Know More
Published on: 11 Apr, 2022
Datar’s TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.
Published on: 14 Feb, 2022
Groundbreaking’ high-sensitivity cancer-screening test arriving in SA ahead of World Cancer Day. Hover to Know More
Published on: 2 Feb, 2022
Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait. Hover to Know More
Published on: 7 Dec, 2021
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics. Hover to Know More
Published on: 19 Nov, 2022
The Top 25 Women Leaders in Biotechnology of 2021 (Swati Deshpande - Datar Cancer Genetics). Hover to Know More
Published on: 19 Oct, 2021
UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'. Hover to Know More
Published on: 13 Jul, 2021
